Second-generation antidepressants and cognitive-behavioural therapy are both viable choices for initial treatment of major depression

ABSTRACT FROM: Amick HR, Gartlehner G, Gaynes BN, et al. Comparative benefits and harms of second generation antidepressants and cognitive behavioral therapies in initial treatment of major depressive disorder: systematic review and meta-analysis. BMJ 2015;351:h6019. What is already known on this topic There is a pressing need to generate clear hierarchies of the benefits and harms of available treatments to implement optimal clinical practice. Second-generation antidepressants (SGAs) and cognitive–behavioural therapy (CBT) have proven efficacy in the treatment of major depression.1 However, comparative benefits and harms of SGAs and CBT for the initial treatment for major depression remain unclear. Methods of the study Amick and colleagues carried out a systematic review and evaluated 11 randomised controlled trials to compare the benefits and harms of SGAs and CBT for the initial treatment of major depressive disorder in 1511 adults. The study included papers published prior to...

Source: Evidence-Based Mental Health - October 20, 2016 Category: Psychiatry & Psychology Authors: Nakagawa, A. Tags: Miscellaneous Source Type: research